Telmikind AM Tablet

Drug | Tablet

Treatment of hypertension (high blood pressure), especially when single-drug therapy is not sufficient; helps reduce risk of cardiovascular events associated with uncontrolled BP.

Telmisartan is an angiotensin II receptor blocker (ARB) that relaxes blood vessels by blocking angiotensin II at AT1 receptors, lowering blood pressure. Amlodipine is a calcium channel blocker (dihydropyridine) that reduces calcium entry into vascular smooth muscle, causing vasodilation and further BP reduction.

Oral tablet. Take once daily at the same time each day, with or without food, as prescribed by the doctor. Swallow whole with water; do not stop abruptly without medical advice.

Dizziness, headache, ankle/foot swelling (peripheral edema), flushing, fatigue, palpitations, nausea

Not recommended in pregnancy (can harm fetus); stop and consult doctor if pregnancy occurs. Use with caution in kidney disease, renal artery stenosis, dehydration/low blood pressure, liver impairment, and in patients on diuretics. Monitor blood pressure, kidney function (serum creatinine) and potassium as ARBs may cause hyperkalemia. May cause dizziness—avoid driving if affected. Rare angioedema can occur; seek urgent care for facial/lip/tongue swelling or breathing difficulty.

Potassium supplements/salt substitutes and potassium-sparing diuretics (risk of hyperkalemia), ACE inhibitors or aliskiren (increased renal risk; avoid in diabetes with aliskiren), NSAIDs (reduced effect and kidney risk), lithium (toxicity risk), other antihypertensives (additive hypotension), strong CYP3A4 inhibitors (may increase amlodipine levels), grapefruit juice (may increase amlodipine exposure in some patients).